JP2019507165A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019507165A5 JP2019507165A5 JP2018545843A JP2018545843A JP2019507165A5 JP 2019507165 A5 JP2019507165 A5 JP 2019507165A5 JP 2018545843 A JP2018545843 A JP 2018545843A JP 2018545843 A JP2018545843 A JP 2018545843A JP 2019507165 A5 JP2019507165 A5 JP 2019507165A5
- Authority
- JP
- Japan
- Prior art keywords
- imatinib
- administered
- dose
- day
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1650260A SE539450C2 (en) | 2016-02-29 | 2016-02-29 | Imatinib for use in the treatment of stroke |
| SE1650260-1 | 2016-02-29 | ||
| PCT/SE2017/050183 WO2017151043A1 (en) | 2016-02-29 | 2017-02-27 | Imatinib for use in the treatment of stroke |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019507165A JP2019507165A (ja) | 2019-03-14 |
| JP2019507165A5 true JP2019507165A5 (cg-RX-API-DMAC7.html) | 2020-04-09 |
| JP6914957B2 JP6914957B2 (ja) | 2021-08-04 |
Family
ID=59744327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018545843A Active JP6914957B2 (ja) | 2016-02-29 | 2017-02-27 | 脳卒中の処置における使用のためのイマチニブ |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US10953010B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3423060B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6914957B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN108697711A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017227515B2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3423060T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2895432T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20211621T1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE056798T2 (cg-RX-API-DMAC7.html) |
| LT (1) | LT3423060T (cg-RX-API-DMAC7.html) |
| PL (1) | PL3423060T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT3423060T (cg-RX-API-DMAC7.html) |
| RS (1) | RS62465B1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2739382C1 (cg-RX-API-DMAC7.html) |
| SE (1) | SE539450C2 (cg-RX-API-DMAC7.html) |
| SI (1) | SI3423060T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017151043A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10617756B2 (en) * | 2017-01-05 | 2020-04-14 | Shimojani, LLC | Drug regimen for treatment of cerebral ischemia |
| CN114306342B (zh) * | 2020-09-30 | 2024-06-28 | 江苏先声药业有限公司 | 一种注射用伊马替尼盐的药物组合物及其制备方法 |
| CN118524852A (zh) * | 2021-11-09 | 2024-08-20 | 真和制药有限公司 | 治疗或抑制心血管疾病的方法 |
| EP4311539A1 (en) | 2022-07-29 | 2024-01-31 | Artorange Ltd. | Imatinib formulation for parenteral administration |
| US20250000934A1 (en) | 2023-06-28 | 2025-01-02 | Pharmazz, Inc. | Lyophilized sovateltide-based injectable formulation and method for preparation thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY148074A (en) * | 2005-05-10 | 2013-02-28 | Novartis Ag | Pharmaceutical compositions comprising imatinib and a release retardant |
| WO2007124308A2 (en) * | 2006-04-17 | 2007-11-01 | Ludwig Institute For Cancer Research | Methods and compositions for modulation of blood-neural barrier |
| US7977348B2 (en) * | 2006-04-27 | 2011-07-12 | Sicor Inc. | Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α |
| WO2008051597A1 (en) * | 2006-10-26 | 2008-05-02 | Sicor Inc. | Process for the preparation of imatinib |
| US20100136094A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems for modulating inflammation |
| HUE044688T2 (hu) * | 2009-03-27 | 2019-11-28 | Moleac Pte Ltd | Terápia sejtnövekedés elõsegítésére |
-
2016
- 2016-02-29 SE SE1650260A patent/SE539450C2/en not_active IP Right Cessation
-
2017
- 2017-02-27 HU HUE17760399A patent/HUE056798T2/hu unknown
- 2017-02-27 WO PCT/SE2017/050183 patent/WO2017151043A1/en not_active Ceased
- 2017-02-27 RS RS20211286A patent/RS62465B1/sr unknown
- 2017-02-27 CN CN201780013732.6A patent/CN108697711A/zh active Pending
- 2017-02-27 AU AU2017227515A patent/AU2017227515B2/en active Active
- 2017-02-27 LT LTEPPCT/SE2017/050183T patent/LT3423060T/lt unknown
- 2017-02-27 US US16/080,529 patent/US10953010B2/en active Active
- 2017-02-27 RU RU2019122730A patent/RU2739382C1/ru active
- 2017-02-27 ES ES17760399T patent/ES2895432T3/es active Active
- 2017-02-27 JP JP2018545843A patent/JP6914957B2/ja active Active
- 2017-02-27 HR HRP20211621TT patent/HRP20211621T1/hr unknown
- 2017-02-27 PL PL17760399T patent/PL3423060T3/pl unknown
- 2017-02-27 EP EP17760399.0A patent/EP3423060B1/en active Active
- 2017-02-27 DK DK17760399.0T patent/DK3423060T3/da active
- 2017-02-27 PT PT177603990T patent/PT3423060T/pt unknown
- 2017-02-27 CN CN202411509669.3A patent/CN119523986A/zh active Pending
- 2017-02-27 SI SI201730931T patent/SI3423060T1/sl unknown
-
2021
- 2021-02-26 US US17/186,303 patent/US20210236488A1/en not_active Abandoned